Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics capability available within its NxView 4.0 software platform for the NxStage System One in the United States. TherapyWise provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings by aggregating existing therapy and device data to support identification of trends related to workflow interruptions, alarm burden, and variability. The platform consolidates data generated at the point of care and presents longitudinal summaries intended to support oversight of KRT programs across ICU units and time periods. It securely transmits data from the NxStage System One with NxView to a cloud-based platform, displaying program-level metrics including average delivered dose compared with set dose, average treatment time per cartridge, and alarm frequency trends. The software is intended for retrospective review and program oversight, not for real-time, patient-specific clinical decision-making.
Fresenius Medical Care AG & Co. KGaAFresenius Medical Care introduces TherapyWise, a new cloud-based analytics capability for its NxStage System One, enhancing its product offering.